Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | LKFT | HRMY | ||
| Company | Urogen Pharma Ltd | Lakefront Biotherapeutics | Harmony Biosciences Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.81 | 29.61 | 33.43 | ||
| High | 41.88 | 30.04 | 34.22 | ||
| Low | 39.50 | 29.60 | 33.36 | ||
| Latest | 40.23 | 30.01 | 33.77 | ||
| Change | +0.23 | +0.41 | +0.24 | ||
| % Change | +0.57% | +1.39% | +0.72% | ||
| Volume | 1,265,198 | 480,808 | 698,185 | ||
| 20-Day Average Volume | 822,420 | 164,295 | 850,904 | ||
| Previous Close | 40.00 | 29.60 | 33.53 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 37.38 | 29.71 | 35.54 | ||
| 20-Day Raw Stochastic | 82.94% | 69.19% | 22.89% | ||
| 20-Day Relative Strength | 71.22 | 56.10 | 47.73 | ||
| Weighted Alpha | +161.69 | -4.97 | -0.35 | ||
| Today's Opinion | 100% Buy | 8% Sell | 64% Buy | ||
| Previous Opinion | 100% Buy | 48% Sell | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.33% since 07/10/26 | -0.86% since 07/10/26 | -8.33% since 07/10/26 | ||
| Low | 36.81 on 07/13/26 | 29.36 on 07/15/26 | 32.25 on 07/16/26 | ||
| High | 41.88 on 07/17/26 | 30.24 on 07/13/26 | 36.96 on 07/13/26 | ||
| 1-Month | |||||
| %Chg | +22.62% since 06/17/26 | +5.78% since 06/17/26 | unch since 06/17/26 | ||
| Low | 32.21 on 06/18/26 | 28.00 on 06/22/26 | 32.25 on 07/16/26 | ||
| High | 41.88 on 07/17/26 | 30.91 on 07/08/26 | 38.89 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +78.48% since 04/17/26 | +2.49% since 04/17/26 | +12.60% since 04/17/26 | ||
| Low | 22.07 on 04/20/26 | 26.42 on 05/19/26 | 28.74 on 04/20/26 | ||
| High | 41.88 on 07/17/26 | 30.91 on 07/08/26 | 38.89 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +113.99% since 01/16/26 | -10.47% since 01/16/26 | -6.76% since 01/16/26 | ||
| Low | 16.50 on 03/30/26 | 26.42 on 05/19/26 | 25.90 on 02/24/26 | ||
| High | 41.88 on 07/17/26 | 36.24 on 02/24/26 | 38.89 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,948,880 | 1,950,551 | 1,941,152 | ||
| Shares Outstanding, K | 48,722 | 65,897 | 57,893 | ||
| Annual Sales | 109,790,000 | 1,258,400,000 | 868,450,000 | ||
| Annual Net Income | -153,490,000 | 363,050,000 | 158,690,000 | ||
| Last Quarter Sales | 50,960,000 | 7,590,000 | 215,390,000 | ||
| Last Quarter Net Income | -23,570,000 | 16,960,000 | 32,490,000 | ||
| 60-Month Beta | 1.56 | 0.25 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 05/06/26 | 0.25 on 05/06/26 | 0.55 on 05/07/26 | ||
| Earnings Date | 08/06/26 | N/A | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 14.07 | ||